2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Pediatric and Young Adult Cancer Incidence in the United States During the COVID-19 Pandemic.Pediatric blood & cancer · 2025
   Article
2. Influence of the COVID-19 pandemic on the incidence and mortality of primary spinal tumors in the United States: A SEER analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
   Article
3. Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma.Journal of gastrointestinal oncology · 2024
   Article

Corrections and comments

• Comment on
  Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.2023

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as